News | Proton Therapy | February 01, 2019

Stephenson Cancer Center is one of three locations in the world with Mevion’s S250i system with Hyperscan pencil beam scanning technology

University of Oklahoma Cancer Center Begins First Proton Therapy Treatments

February 1, 2019 — Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (The University of Oklahoma) Medicine has commenced proton therapy treatments with the Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning. Cleared by the U.S. Food and Drug Administration (FDA) in 2017, Hyperscan improves on existing scanning capabilities to deliver conformal fields of therapeutic radiation to tumors faster with more precision.

“We are excited to offer our patients this advanced radiation therapy,” said Terence Herman, M.D., radiation oncologist at the Stephenson Cancer Center. “We provide a full range of treatment options, which ensures patients can stay in Oklahoma to receive the best possible care. Proton therapy is yet another important tool we can use in the fight against cancer, and the Mevion Hyperscan system provides a level of precision that far exceeds that of earlier, non-focused proton treatment techniques.”

As part of OU Medicine’s National Cancer Institute-designated cancer center, the single-room compact proton system is embedded directly into the radiation oncology department. This efficient approach enables the cancer center to share existing resources and give patients access to OU Medicine’s robust collection of cancer-fighting therapies under one roof.

OU Medicine anticipates using the new system to treat brain tumors, select head-and-neck tumors, abdominal tumors such as pancreatic cancer, some rare neural tumors, localized prostate cancer and essentially all tumors in pediatric patients. Several research projects are planned as well.

For more information: www.mevion.com

Related Content

Videos | Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
News | Radiation Therapy

November 17, 2021 — Radiation can be a powerful cancer therapy, but it doesn’t work for everyone. A new study identifies ...

Time November 17, 2021
arrow
Videos | Radiation Oncology

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
News | Prostate Cancer

November 16, 2021 — A new Harvey L. Neiman Health Policy Institute study of nearly 800,000 men found that between 2011 ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Videos | Radiation Therapy

Anthony Zietman, M.D., interim chief, radiation oncology, Mass General Cancer Center, and former president of the ...

Time November 15, 2021
arrow
Videos | Radiation Therapy

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
arrow
Subscribe Now